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Abstract 26 
Prevention of mother-to-child transmission (PMTCT) can virtually eliminate HIV transmission to 27 
infants, yet up to one-third of women miss PMTCT steps. Little is known about how partner 28 
dynamics such as intimate partner violence (IPV) influence pregnant and postpartum women’s 29 
adherence to PMTCT. We conducted 32 qualitative interviews with HIV-positive pregnant and 30 
postpartum women in Johannesburg who experienced IPV. Trained researchers conducted in-31 
depth interviews over the period of May 2014 – Nov 2015 using narrative and social 32 
constructionist approaches. Interviews were transcribed verbatim and analyzed thematically and 33 
inductively using qualitative software. Twenty-six women experienced recent IPV and one-third 34 
had poor adherence to PMTCT. Women’s experience of violence influenced PMTCT behaviors 35 
through four pathways. First, fear of partner disclosure led women to hide their HIV status to 36 
 2 
avoid a violent reaction. Despite non-disclosure, some maintained good adherence by hiding 37 
medication or moving out from their partner’s home. Second, IPV caused feelings of depression 38 
and anxiety that led to intentionally or accidentally missing medication. Five women stopped 39 
treatment altogether as a kind of passive suicidality, hoping to end the distress of IPV. Third, 40 
men’s controlling behaviors reduced access to friends and family, limiting social support needed 41 
for good adherence. In a protective pathway, women reported good adherence partly due to their 42 
mothering role. Fourth, motherhood identity was used as a coping technique, reminding women 43 
that their infant’s wellbeing depended on their own health. PMTCT is essential to prevent vertical 44 
HIV transmission, but women living with IPV face multiple pathways to non-adherence: partner 45 
non-disclosure, mental health, and partner control and isolation. Protective factors like “striving 46 
for motherhood” may lessen the relationship between IPV and PMTCT. Addressing IPV in 47 
antenatal care can support the health of mothers and infants and may enhance PMTCT coverage. 48 
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 51 
Introduction 52 
Prevention of mother-to-child transmission (PMTCT) interventions have potential to eliminate 53 
vertical transmission of HIV from mothers to infants (Mofenson, 2010). Yet, women’s adherence 54 
to all the steps required for successful PMTCT is often low. Within 21 priority countries, an 55 
estimated 65% of eligible pregnant women access HIV treatment (WHO et al., 2013), and pooled 56 
analysis suggests that only half of women adhere to treatment postpartum (Nachega et al., 2012). 57 
Studies in sub-Saharan Africa suggest that partner relationship factors are among the most 58 
important barriers to pregnant women’s acceptance of HIV testing and other PMTCT behaviors 59 
(Bwirire et al., 2008; Medley et al., 2004; Turan et al., 2011). Intimate partner violence (IPV) 60 
may be one important predictor of adherence to HIV medication in pregnancy and postpartum, 61 
yet this association has been understudied in the literature to date (Hatcher et al., 2015). 62 
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Among non-pregnant women, IPV victimization is associated with worse HIV-related 63 
health outcomes, including higher odds of antiretroviral failure, weaker immune response, 64 
increases in opportunistic infections, and greater risk of mortality (Schafer et al., 2012; Weber et 65 
al., 2012). A meta-analysis suggested that women’s experience of IPV was associated with 55% 66 
lower odds of self-reported adherence and 36% decreased odds of viral suppression (Hatcher et 67 
al., 2015). However, of the thirteen included studies, none were based in sub-Saharan Africa or 68 
among pregnant women. Since publication of the meta-analysis, only a single study has examined 69 
the effect of IPV on adherence in pregnant women. This Zambian study showed that IPV 70 
victimization was associated with 74% lower odds of adherence in pregnancy and 89% lower 71 
odds of adherence postpartum (Hampanda, 2016). . However, the quantitative methods used by 72 
this seminal paper preclude a deeper understanding of how partner violence alters PMTCT 73 
behaviors. This is a crucial dynamic to understand, particularly since many of the same countries 74 
in sub-Saharan Africa with the highest rates of mother-to-child transmission also have high 75 
prevalence of IPV (Devries et al., 2013). 76 
South Africa is one such sub-Saharan African setting where HIV and IPV are highly 77 
prevalent. An estimated 25 – 35% of South African pregnant women report recent physical and/or 78 
sexual IPV (Groves et al., 2012; Hoque et al., 2009). Similarly, antenatal HIV prevalence across 79 
South Africa is high, with estimates in Johannesburg reaching 29% (Department of Health, 2012). 80 
South Africa has made significant strides towards reducing mother-to-child transmission from 81 
14% in 2009 to an estimated 5% in 2012 (UNAIDS, 2013). Yet, only 54-65% of South African 82 
pregnant women and infants complete all recommended PMTCT steps (Stringer et al., 2010; 83 
Technau et al., 2014).  84 
Recent qualitative studies have explored the underlying dynamics of IPV among small 85 
samples of women living with HIV. Among 8 women reporting violence after HIV disclosure, 86 
Colombini et al. learned that new HIV diagnosis was a trigger for violence, even in relationships 87 
with no prior history of IPV (Colombini et al., 2016). Mulranen et al. studied postpartum women 88 
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living with HIV in Swaziland, of whom 9 reported IPV following disclosure, and learned that 89 
violence resulted from acute triggers like HIV status disclosure and also from ongoing marital 90 
tensions around fertility (Mulrenan et al., 2015). In a study of pregnant and postpartum HIV-91 
positive women in the United States, Njie-Carr et al. found that 3 women with recent violence 92 
avoided partner disclosure because they feared a violent reaction (Njie-Carr et al., 2012). 93 
Illangesekare et al. identified mental health as a primary pathway linking IPV to non-adherence 94 
among HIV-positive women reporting lifetime partner violence, of whom 3 were currently living 95 
with IPV (Illangasekare et al., 2014). Other qualitative research has broadly explored violence 96 
and HIV medication adherence, but not among women who present with both conditions (Hatcher 97 
et al., 2014; Zunner et al., 2015). While extant qualitative offers preliminary understanding that 98 
perhaps violence and HIV behaviors are linked, samples sizes ranging from 3-9 participants rule 99 
out the analytical rigour required to understand why IPV alters adherence. 100 
Qualitative elucidation of the mechanisms linking IPV and HIV adherence is necessary if 101 
we are to increase the proportion of women adhering to PMTCT interventions. We conducted in-102 
depth qualitative research with 32 women living with HIV and reporting experience of IPV in 103 
Johannesburg, South Africa. The purpose of the research was to explore mechanisms linking 104 
these interconnected issues among pregnant and postpartum women.  105 
 106 
Theoretical framework 107 
This research was informed by an integrated socio-ecological, dyadic conceptual framework (Fig. 108 
1). The socio-ecological model suggests that individual, relationship, and structural factors shape 109 
health outcomes (Heise, 1998), and is widely used in IPV research because it incorporates many 110 
complex factors that influence partner violence (WHO, 2010).  111 
Within the ecological model, individual factors are the personal characteristics or 112 
behaviours that impact one’s health. Previous literature has suggested that individual factors 113 
inhibiting PMTCT uptake include depression (Nachega et al., 2012; Turan et al., 2013), substance 114 
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use (Nachega et al., 2012), internalized HIV stigma and shame (Turan et al., 2013), and costs 115 
associated with clinic attendance (Bwirire et al., 2008). Partner relationship factors are the 116 
dyadic partnership issues that frame health outcomes. Partner dynamics that worsen PMTCT 117 
behaviors include a lack of male involvement in antenatal care (Aluisio et al., 2011), non-118 
disclosure to a partner (Gourlay et al., 2013; Myer, 2011), and threat of further violence 119 
(Antelman et al., 2001). The theory of gender and power (Connell, 1985), which postulates that 120 
unequal power dynamics limit the ability of women to exercise personal control in relationships 121 
(Amaro & Raj, 2000), provides a theoretical underpinning for the associations seen between 122 
partner factors and PMTCT uptake. Structural factors refer to the broader social or community 123 
factors that impact on health. In this sphere, previous studies have noted that PMTCT is adversely 124 
impacted by poverty (hIarlaithe et al., 2014), lack of social support (Kirsten et al., 2011), 125 
community stigma around HIV (Turan et al., 2011), and weak health systems (Bwirire et al., 126 
2008). A socio-ecological framework recognises that similar structural factors underpin both 127 
violence and HIV (Maman et al., 2000) and that broader social and societal factors shape 128 
women’s ability to adhere to HIV medication (Hirsch, 2007) and the extent to which they 129 
experience IPV (Heise, 1998). 130 
 131 
INSERT FIGURE 1 ABOUT HERE 132 
Methods 133 
The goal of this qualitative research was to build understanding around why and how IPV 134 
influences PMTCT uptake and HIV-related health. This analysis is guided by formative 135 
qualitative research with pregnant women and health providers (Hatcher et al., 2014). The 136 
formative research included no women living with IPV and HIV, but rather asked participants to 137 
speculate about the links between violence and PMTCT. As an elucidation of mechanisms 138 
requires knowledge of women who actually experience these health conditions, we now present 139 
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data from in-depth interviews with a larger sample of women (n=32) living with both IPV and 140 
HIV.  141 
Qualitative research was nested within a randomised control trial testing an intervention 142 
for IPV in pregnancy (Pallitto et al., in submission). Called Safe & Sound, the trial recruited 1680 143 
pregnant women from four antenatal clinics in Johannesburg to take part in baseline 144 
questionnaires. In the parent trial, women reporting recent (past-year) physical and/or sexual IPV 145 
(n=421) were randomised to a nurse-led empowerment counseling intervention or an enhanced 146 
control condition. This sub-study purposively selected the sample of 32 participants to take part 147 
in qualitative, in-depth interviews between May 2014–November 2015. 148 
The methodology for this study was informed by narrative, constructionist approaches to 149 
researching IPV (Allen, 2011). The narrative element of this approach posits that discussing IPV 150 
experiences with skillful providers can be therapeutically beneficial and that the research process 151 
itself serves as a form of reflection for participants (Allen, 2011). Narrative approaches to 152 
research on violence acknowledge that women’s stories help create coherence in otherwise 153 
chaotic, uncontrollable situations (Williamson, 2010). Narrative approaches use particular 154 
techniques during the interview process, such as validation, highlighting resistance strategies, and 155 
focusing on meaning and identity (Allen, 2011). The social constructionist methodology 156 
acknowledges that researchers are part of the research interaction and that their prior knowledge 157 
should be brought to light and examined (Charmaz, 2008).  158 
 159 
Participant sampling and recruitment 160 
We conducted qualitative research with 32 participants who were purposively selected from 161 
women taking part in baseline Safe & Sound trial questionnaires. Women recruited for this 162 
sample were living with HIV and experiencing IPV. In practice, this included women 163 
participating in the trial (ie. experiencing recent IPV), as well as women who were not eligible to 164 
enroll in the trial, but who had experienced IPV in their lifetime. These lifetime history 165 
 7 
participants had already completed a full study baseline questionnaire and agreed to be contacted 166 
about further research. Study nurses guided the selection of participants based on their impression 167 
of women’s willingness to take part in an additional interview, their knowledge of women’s 168 
experiences of IPV, and women’s HIV-positive status. 169 
Initially, the sample size proposed for this qualitative study was 24 participants. Using 170 
the constant comparative method to understand the emerging constructs from the data (Charmaz, 171 
2003), we found that upon completion of 18 interviews, theoretical saturation had not yet been 172 
reached. Data on our initial research question around links between violence and PMTCT lacked 173 
richness and women’s stories failed to converge around specific pathways. We thus expanded the 174 
sample to reach 32 women using theoretical sampling to include additional women with recent 175 
IPV experiences. Theoretical sampling is a technique for using preliminary analysis to guide how 176 
data are collected further (Glaser, 1992). In this case, our initial analysis suggested that links 177 
between violence and PMTCT are best explored among participants with recent violence and 178 
with some challenges adhering to PMTCT behaviors. Displaying “challenges” with PMTCT was 179 
therefore used as a selection criteria for the next 14 participants. Additional women with these 180 
characteristics allowed us to further refine emergent concepts and test out initial impressions of 181 
the data with a more targeted group of participants. 182 
Trained nurse researchers invited women to participate through follow-up phone calls 183 
using locator information. All participants contacted for this sub-study were reachable by phone, 184 
with 7 women refusing to take part (due to living outside the province, work commitments, or not 185 
desiring to take part in additional research). Male partners were never informed about a woman's 186 
participation in the research because of the potential for an abusive partner to react violently. To 187 
protect participants and reduce the risk that partners would overhear the conversation, nurses 188 
were trained to ask “is this a safe time to speak?” before continuing. A full distress protocol 189 
included appropriate researcher responses in cases of violence disclosure, psychological distress, 190 
high emotionality, or a need for referrals. Basic elements of the distress protocol were employed 191 
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during most interviews included in this study: a calm, non-judgmental approach to inquiry; 192 
watching for signs of resistance when inquiring about violence to avoid re-traumatisation; 193 
offering tissues if participants cried; offering a break from the interview. In cases of severe 194 
distress, researchers were trained to invite participants to stop the interview, a technique that was 195 
used with one participant, and to offer supportive referrals. In the case of current suicidal thinking, 196 
researchers were trained to make a direct referral to a psychiatric ward of the nearest hospital. In 197 
this sample, no participants revealed current suicidal thinking but several participants recounted a 198 
history of suicidal ideation, for which researchers offered empathetic listening and referrals to a 199 
nearby community psychology counseling service. 200 
 201 
Data collection 202 
In-depth interviews were conducted face-to-face, in a private clinic room, at a convenient time for 203 
the woman.  Interviews were conducted by the lead author and three other trained qualitative 204 
researchers. The trained researchers were comprised of two South African, female nurses and two 205 
non-South African, female researchers. This composition of the research team helped ensure that 206 
some of the positionality challenges associated with language and race were addressed. However, 207 
all researchers held positions of relative power compared to participants, a dynamic that was 208 
intentionally addressed through training on a humble, inquisitive approach and the ethos among 209 
the research team that participants were the ‘experts’ and researchers were the ‘learners’. While 210 
this positionality could not be completely eliminated, the rich stories presented by most 211 
participants suggests comfort in sharing their stories through the research process. 212 
Interviews were conducted in one of three South African languages (English, Sesotho, 213 
isiZulu) and digitally recorded. A semi-structured in-depth interview guide explored three 214 
themes: the perceived relationship between IPV and HIV in women’s lives; women’s perceptions 215 
of how violence may influence PMTCT uptake; and, potential mechanisms through which IPV 216 
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may impact PMTCT-related health behaviors. Interviews lasted between 26 minutes and 1 hour 217 
40 minutes (median 46 minutes).  218 
Professional transcriptionists typed verbatim transcripts from the digital recordings. Each 219 
transcript was reviewed by a researcher to ensure clarity and for additional detail about tone and 220 
non-verbal cues.. Interviews conducted in the local language (Sesotho or isiZulu) were translated 221 
directly to English and reviewed for translation errors by the researcher who led the interview. All 222 
data collection materials were stored in a locked file cabinet and electronic voice files and 223 
transcripts were password protected and stored on an encrypted server. At the point of 224 
transcription, the lead researcher assigned a pseudonym unrelated to the participant’s real name 225 
for ease of analysis. The data presented here note the pseudonym, age, and whether the woman 226 
was pregnant or postpartum. 227 
 228 
Data analysis 229 
To ensure that interviews achieved adequate depth and richness, the first 6 transcripts were 230 
reviewed jointly to establish future questions, points of clarification, and initial themes. 231 
Researchers reviewed full transcripts and created detailed 'memos' to highlight initial impressions 232 
of the data. This review process was repeated at two other time-points (upon completion of 18 233 
interviews and 28 interviews). Both reviews led to tweaking of the interview guides, with major 234 
themes retained but sub-questions altered to enhance probing and clarity. The team developed an 235 
initial coding framework based on the preliminary review of 6 transcripts and “sensitizing 236 
concepts”, or preliminary ideas around how to examine the data (Bowen, 2006).  237 
The coding framework was applied to all transcripts by two researchers using Dedoose 238 
qualitative analytic software. The focus of double-coding was to ensure that code application was 239 
consistent across transcripts and that code definitions were robust. Rather than assessing inter-240 
rater reliability, the team used a series of phone calls and in-person meetings to refine codes until 241 
consensus was reached. This process led to a refined set of thematic codes that comprised broad 242 
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topics such as relationship characteristics, experience of violence, HIV diagnosis, PMTCT uptake, 243 
mental health, social support, partner HIV serostatus disclosure, and reflections on being asked 244 
about IPV in pregnancy. Next, the team established a system of fine codes that emerged 245 
inductively from the data. Fine codes were applied to a portion of transcripts by three researchers, 246 
ensuring that every transcript was double-coded. Examples of fine codes within the partner HIV 247 
disclosure section were: fear of partner response, reactive or polarized methods of disclosure, 248 
male partner denial of disclosure, concern for the child, supportive steps, displaced anger. During 249 
analysis, cases that did not fit the overall picture, called “exceptional cases”, were actively sought 250 
out. Trustworthiness of findings was ensured by the team approach to data analysis, coding 251 
discussion meetings, and by presenting initial findings to groups of colleagues and peers.  252 
 253 
Ethical and safety considerations 254 
All participants provided written, informed consent. The parent trial received approval from the 255 
University of the Witwatersrand Human Research Ethics Committee (M121179) and World 256 
Health Organization Ethics Research Committee (RPC471). This qualitative substudy received 257 
additional secondary analysis approval from University of the Witwatersrand (M140451). 258 
Given the special considerations around researching violence, all portions of this study 259 
were designed to adhere to the WHO ethical and safety guidance on IPV research (WHO, 2001). 260 
The research was presented broadly so that the specific nature of the study was not made public. 261 
Only when the participant and interviewer were alone, during the informed consent process, did 262 
the researcher provide further information that the nature of the study involved HIV and IPV. All 263 
qualitative researchers were intensively trained. A 30-hour technical training alongside weekly 264 
mentorship and debriefing by senior team members ensured all researchers had the knowledge 265 
and skills required to skillfully handle disclosure of violence (Reynolds, 2007).  266 
 267 
Results 268 
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Sample characteristics 269 
Of the 32 participants, 26 women reported IPV in pregnancy while 6 reported a prior history of 270 
IPV (see characteristics summarized in Table 1).  The majority of participants (75%) reported 271 
physical and emotional violence, with several (16%) reporting physical, sexual, and emotional 272 
violence. Twelve participants (38%) reported that they were non-adherent to HIV medication 273 
during the time of pregnancy or were not on treatment. 274 
 275 
INSERT TABLE 1 ABOUT HERE 276 
 277 
Links between violence and PMTCT adherence 278 
We learned that four pathways linked women’s experience of IPV with their adherence to 279 
PMTCT interventions. The first pathway was partner disclosure, with violent relationships 280 
framing a decision to hide one’s HIV status. Some women were unable to maintain careful 281 
PMTCT behaviors without risking disclosure, so they opted to take treatment breaks or stop 282 
treatment altogether. A second pathway was mental health, as IPV resulted in depressive views 283 
that “life is not worth living” and led to missing doses of medication. A third pathway was partner 284 
control and isolation, in which men limited participant access to friends and family, which 285 
precluded the social support required for good adherence. In a final, protective pathway, good 286 
PMTCT adherence seemed linked to women’s identity as mothers, with the wellbeing of the baby 287 
framing decisions to stay attentive to medication.  288 
Below, we present each pathway alongside illustrative quotes and case examples of 289 
participants. While it may appear that certain women ‘belong’ primarily to one single pathway, 290 
this was certainly not the case within the overall analysis. Participants often related stories that 291 
highlighted the complex relationship across the pathways. 292 
 293 
Partner (Non) Disclosure: Hiding HIV from a partner 294 
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Of the 16 women who disclosed to partners, many experienced subsequent physical violence 295 
(n=6) and emotional violence (n=7) that they directly linked to the disclosure act. Participants 296 
recalled incidents of violence that started or worsened immediately following HIV testing. 297 
Lulama, who was 30 years old and pregnant with her second child, made a direct link between 298 
her HIV status and physical and emotional violence from her partner. The partner consistently 299 
blamed Lulama for “giving” him HIV, and would use threats of further physical violence to show 300 
his disdain for her status. Thuto, a 25-year-old postpartum participant, explained that the violence 301 
in her relationship started when she tested HIV-positive during her first pregnancy. Thereafter, a 302 
severe episode of physical violence in her third pregnancy was directly related to her HIV status: 303 
“He came back from the shebeen [local bar] and said I was a slut, and that’s why I came with this 304 
disease.” 305 
Not all women experienced physical violence after disclosing their HIV status. A tension 306 
occurred in Leah’s relationship that demonstrates the blurred lines between violence and partner 307 
support around HIV. As a 33-year-old pregnant participant, Leah’s husband was broadly 308 
supportive of her taking medication, because Leah had carefully convinced him that PMTCT can 309 
prevent HIV in their infant. Leah’s partner would even remind her of her treatment time. Yet, 310 
alongside this instrumental support, he was emotionally abusive and would remind her that HIV 311 
would lead to her death by stating, “You will die, your children will be alone.”   312 
In this context of violent or psychologically harmful reactions, it is perhaps not surprising 313 
that 16 women opted to keep their HIV status a secret. Participants described this choice as a 314 
reasoned response to a dangerous situation. Six participants feared that their partners would react 315 
to disclosure with physical violence. For Simphiwe, a 33-year-old woman who had been with her 316 
partner for five years, a history of physical violence led her to keep HIV a secret. Another 317 
participant, Kandi, feared physical violence because her partner explicitly stated that he would 318 
hurt her should she test HIV-positive. 319 
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Fears of partner reaction led some women to be partially non-adherent to their HIV 320 
medications. One 32-year-old postpartum participant, Nomsa, described her fear that the father of 321 
her first child might murder her or the child as a response to HIV disclosure. Nomsa kept her 322 
status hidden by pretending the medication was for pregnancy, rather than for HIV, but admitted 323 
it was challenging to keep taking the pills after giving birth. Another participant, Thembi, was 26 324 
years-old and postpartum when she recounted how she chose not to start HIV medication in 325 
pregnancy because she was frightened that her partner would be physically violent when she 326 
asked him to use a condom. Her (incorrect) understanding of treatment came from antenatal staff 327 
who often say that HIV medication must be accompanied by consistent condom use. Since 328 
Thembi knew she could not safely use condoms, she chose to avoid HIV medication altogether. 329 
Her non-uptake of treatment meant that her infant acquired HIV during the course of the study.  330 
The act of hiding medication and withholding one’s status from partners requires 331 
considerable foresight and care. Lulama, 30 years and pregnant during the interview, strategically 332 
took medication at a time when her husband was away from the house. At 34 years and pregnant, 333 
Ayanda changed the container of her HIV medication so that it would appear to be other routine 334 
medication. Other women like Mpefe also had to carefully navigate clinic visits and medication: 335 
My boyfriend doesn't know about this.  I just kept it to myself. So my treatments, 336 
when I would come and take my treatments here by the clinic, then I would hide 337 
it by my place.  Even when I drink my tablets I would hide them. – Mpefe, 25 338 
years, Pregnant 339 
When Mpefe noticed her partner was nearby, she would forgo treatment altogether. Eventually, 340 
Mpefe decided to move out so that she could easily take her treatment without worry that her 341 
boyfriend might see.  342 
Similarly, Zama (25 years and pregnant) found it easier to adhere to medication once she 343 
moved out from her partner’s place. Before she would wait until he fell asleep to take her daily 344 
prescription: “It was a little bit tricky because I had to hide the medication. And then at times he 345 
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would be in the same bedroom where I hide it, so I can’t take it.” For Sonja, the original response 346 
to disclosure was threats of violence and forced eviction from the household. In this context, 347 
Sonja, 23-years-old and pregnant, carefully avoided taking medication in front of her partner, 348 
worrying that simply seeing the medicine might trigger a violent reaction. One day, her partner 349 
snuck up on her in the bathroom and caught her taking the treatment. While the response was not 350 
physical violence, her partner disappeared and returned home in an agitated state after a bout of 351 
drinking. 352 
A subtler rationale for hiding medication from violent partners was to withhold 353 
information from a person who had caused so much pain. For two women, this appeared to be a 354 
resistance strategy for proving to themselves that their own health was not within the realm of 355 
things men could control. Simphiwe professed that she made up her mind immediately after 356 
testing HIV positive, since “he was violent, hitting me and all that stuff. So I decided I’m not 357 
going to tell him.” Similarly, Zinhile explained “If he was a proper person, then I would tell him 358 
that I’m HIV positive, let’s go to the hospital together to test. But if he is going to put me at risk, 359 
why should I say that?” Zinhile met her partner’s lack of care by stubbornly refusing to share 360 
anything about HIV with him: 361 
I didn’t want him to know I have gone to the clinic. I didn’t even want him to 362 
know what I was doing in my life, in my future, because he didn’t want to be 363 
close… I didn’t even want him to see me taking the tablets, because he didn’t 364 
want to know, he didn’t want me. – Zinhle, 38 years, Postpartum 365 
 366 
Mental health: Poor adherence as a result of depression and anxiety 367 
Several women related stories of non-adherent periods, many of which resulted from depressive 368 
episodes that followed phases of violence. At 24 years, Thuto had recently delivered her fourth 369 
child, and explained the tendency to feel despondent particularly after extremely violent episodes 370 
or when her husband refused to buy food for the family. Thuto sometimes struggled with staying 371 
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adherent, and explained that she had given up hope:  “Sometimes, when I’m stressed, I feel that 372 
its better I also died… I’ve just lost hope.” Zama expressed a concern that her infant would test 373 
HIV-positive, since she herself had experienced adherence struggles. Similar to several other 374 
participants, Zama disclosed a desire to “end everything” as a method to reduce the distress she 375 
was feeling about the violent relationship: 376 
When I was three months pregnant, that is when it started changing to being 377 
physical [violence]. At times I would just feel like ending everything, the stress 378 
and all that… I am very much worried about my baby being positive, especially 379 
with the fact that I was not able to take my medication as frequently as I was 380 
supposed to. –Zama, 25 years, Pregnant 381 
Ayanda’s partner had been physically abusive the night before the interview. She described the 382 
physical violence alongside the overwhelming nature of coping with frequent abusive episodes 383 
and anticipating the arrival of a new baby. The stress related to the violence was a concern 384 
because Ayanda realised how episodes of IPV took priority over remembering to take her 385 
medication: 386 
You know what bothers me sometimes? That when he makes this thing [violence], 387 
I may forget to drink my medication. Then maybe I will just default [not comply 388 
with HIV visits and medications]. And what worries me is that I will default when 389 
I’m breastfeeding the child. –Ayanda, 34 years, Pregnant 390 
This notion of “forgetting” to take medication is perhaps more linked to how women are able to 391 
cope with various life challenges. When violence is more of a concern, or more ‘top of mind’, 392 
than HIV-related concerns, women may forgo the steps required for good HIV care. This finding 393 
denotes how subtle mental health considerations, like being too cognitively overwhelmed by the 394 
violence, may influence PMTCT uptake. 395 
Six women described periods of stopping treatment altogether due to depressive and 396 
suicidal feelings. The underlying emotion of stopping treatment for these women was a desire to 397 
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end their lives. One participant, Dova, named it a “death wish” and recounted the overwhelming 398 
feelings of hopelessness and failure that had led her to stop taking HIV treatment: 399 
There was a time when I was really, really down, so I stopped taking my 400 
medication. I completely just stopped and I sort of had this death wish in me that 401 
if only this thing would, if HIV would work like really for us then it would just kill 402 
me. I stopped for three to four months without taking my medication. – Dova, 32 403 
years, Pregnant 404 
 405 
Another participant, Dintle, had tried to commit suicide by drinking poison several weeks 406 
prior to the interview. Her husband had been extremely violent, hitting her in front of the 407 
neighbours, withholding food, and publicly shaming her. She explained in subtle terms (such as 408 
“stress” and “feeling bad”) how her recent suicidal experience and anxiety symptoms would 409 
cause her to forgo treatment for periods of time: 410 
Participant (P): Sometimes I forget to take my treatment. It happened two months 411 
ago. I had pills, but I just forgot dates to go fetch my treatment.  412 
Researcher (R): What led you to forget? 413 
P: Stress, I am always thinking. 414 
I: What were you thinking? 415 
P: I was thinking about the time he threatened me. I just end up thinking about 416 
too many things. By the time I remember it is too late, my days have passed. – 417 
Dintle, 30 years, Postpartum 418 
For Dintle, stopping treatment was a by-product of experiencing intense episodes of violence and 419 
concomitant mental health challenges. This suggests that in cases of severe depression, HIV 420 
treatment non-adherence can be both a mode of self-harm and a result of being overwhelmed at 421 
times of high distress. 422 
 423 
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Isolation and partner control: The hidden nature of IPV and HIV 424 
In this sample, there were only a few examples of partners directly controlling the health of 425 
women through barring access to clinics or medication. At 38 years and postpartum, Zinhle 426 
feared blame associated with having HIV, but not necessarily a violent reprisal. Even still, the 427 
controlling behaviors her partner exhibited against the backdrop of physical and sexual violence 428 
meant that Zinhle would surreptitiously visit the clinic.  429 
Yet, partner control did not always lead to poor adherence. For example, Kagiso’s partner 430 
was suspicious when she went to the clinic, assuming she was cheating on him. At times, he 431 
would physically abuse her when she came home from the clinic, assuming she was unfaithful 432 
during her times away from home, but she described a stubborn dedication to continue seeking 433 
medical treatment: 434 
Sometimes when I go to the clinic he say hey you are not going to the clinic.  He 435 
asked me too many questions… But I refuse. I tell him I can’t stop going to clinic 436 
because this is my life! I have children. I have to live to take care of my babies. 437 
Sometimes when I come back to the house he beats me, accusing that I’m not 438 
coming from the clinic. –Kagiso, 28 years, Postpartum 439 
 440 
For many women, violent partners did not actively bar access to clinics, but indirectly 441 
used isolation as a type of partner control. One example is found in Lulama’s story about how 442 
returning from a normal day would often result in questions and threats: “He is always looking at 443 
what I do and wants to know what I get up to. He controls my life, he says I should always be at 444 
home.” The outcome of these controlling behaviors was often immense isolation and mental 445 
health challenges for Lulama, who was 30 years and pregnant at time of interview.  446 
For several participants, the feeling of isolation was pervasive, leaving them troubled and 447 
continually ruminating over difficult thoughts. Dova illustrated this by describing how thoughts 448 
of the violence were “stuck in her mind” and left her isolated and alone: 449 
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It is just basically stuck there in my mind - all these things that have been 450 
happening. When you are alone, you just sit and think about it and I don’t have 451 
anyone. Sometimes I don’t sleep the whole night I am thinking and thinking. – 452 
Dova, 32 years, Pregnant 453 
 Another implicit trait of the partner control and isolation pathway is the hidden nature of 454 
both HIV and violence. Both HIV and IPV are stigmatised, which leads to a worsened ability 455 
among women to find support for either condition. Several women spoke of staying silent with 456 
their families about the violence in their relationships. As 30-year-old, pregnant Lulama noted, 457 
“whatever we fight about I keep to myself most of the time.” For Neo, it was easier to pretend 458 
that things were fine than to disclose to her friends that she lived in a violent relationship: 459 
It’s hard to tell people I’ve got a problem, I’m not living a good life, with a 460 
partner that I’m worried, we’re always fighting, things like that. You just pretend, 461 
like now pretending that I’m ok but I’m not ok. – Neo, 28 years, Pospartum 462 
 463 
Motherhood as a coping strategy: protective pathway 464 
Despite immense challenges with HIV, violence, and pregnancy, many women in this sample 465 
exhibited unique coping strategies for adhering to treatment. For some women (n=8), the concept 466 
of motherhood was a source of resilience and helped them stick with HIV medications. At 32 467 
years and postpartum, Nomsa struggled to find clothing and food for her children, but continually 468 
reminded herself that treatment was an essential part of being able to care for her children: “I’m 469 
drinking my tablets. I’m just telling myself that I must help myself and get help. I know I need to 470 
work for my kids rather than die.” 471 
Zama did have trouble with adhering to treatment, and considered suicide during phases 472 
when the physical violence was particularly bad. Yet, at 25 years and pregnant, the reminder of 473 
her new baby would often be enough to return her to thoughts of living and trying to provide for 474 
her baby: “Maybe after a fight, I will be crying, stressed and then I would be like, okay, let me 475 
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just do this [commit suicide], then I would think, ‘No, but let us give this baby a chance’.” It is 476 
important to note that Zama exhibited these methods of “resilience” by focusing on her baby’s 477 
wellbeing even as she struggled with suicidality and isolation. Her story illustrates the complex 478 
relationship within multiple pathways, and shows that IPV’s influence can manifest in 479 
complicated ways. 480 
Grace used the idea of caring for her children as a way to “move on with life” and leave 481 
her violent partner: 482 
Like in future I was thinking like to move on with my life. Do something for my 483 
life and for my kids! That’s what I want now because I’m done with living in the 484 
painful relationship. – Grace, 27 years, Postpartum 485 
Zethu’s baby similarly helped her keep “priorities straight.” As a 21-year-old pregnant woman, 486 
she boldly stated that HIV treatment was more important than her husband, and expressed how 487 
non-adherence was simply going to harm herself: “I’m doing it [PMTCT] for my baby. I don’t 488 
want to stress myself so that I leave the tablets - it’s better to leave that husband and continue 489 
with my tablet.” Beyond Zethu’s commitment to protecting her baby, it appeared that taking care 490 
of her own HIV could be a subtle way to “leave that husband” and regain control over her own 491 
life. 492 
 Not every participant was able to use the notion of motherhood to feel more confident 493 
around HIV treatment. For example, Dova felt that the stress related to the violent relationship 494 
was making her a worse mother – a notion that she illustrated by describing how her suicidal 495 
thoughts were linked to potential infanticide: 496 
I have suicidal thoughts because I don’t have anyone. The only people I have are 497 
my kids. And the worst part is with these suicidal thoughts I am always saying, if 498 
I had to kill myself, I wouldn’t leave my kids behind. I would take them with. If 499 
there is a method whereby I would kill me and my kids, I would do it. So it is just, 500 
it is not well. I am not even a good mother these days. –Dova, 32 years, Pregnant 501 
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Dova’s story reflects upon multiple pathways of mental health and isolation, suggesting again that 502 
pathways may have a dynamic relationship and do not necessarily stand alone as distinct 503 
situations. 504 
 505 
Discussion 506 
This is the first study, to our knowledge, to explore the relationship between violence and HIV 507 
adherence within a relatively robust qualitative sample of 32 pregnant and postpartum women 508 
reporting both HIV and IPV. It highlights that women living with HIV and IPV have unique 509 
challenges to maintaining healthy adherence behaviors around the time of pregnancy. Four key 510 
pathways emerged that link IPV to PMTCT: partner non-disclosure, poor mental health, isolation 511 
due to partner control, and motherhood.   512 
As shown in Figure 2, pathways from IPV to PMTCT outcomes tend to intersect and 513 
collide. Rather than falling into distinct categories, participants often presented stories that fell 514 
within multiple pathways. The pathways seemed to be comprised of both positive and negative 515 
aspects of responding to IPV. So while mental health and partner control/isolation seemed to 516 
worsen HIV outcomes for women, pathways of motherhood and partner non-disclosure 517 
highlighted unique resilience strategies used by women. This nuanced understanding of the IPV–518 
HIV adherence relationship can help contextualize recent conflicting evidence from sub-Saharan 519 
Africa. Whereas one study with pregnant women in Zambia showed that violence worsens HIV 520 
adherence (Hampanda, 2016), another in Kenya among female sex workers suggests that history 521 
of IPV actually improved odds of HIV-related health (Wilson et al., 2016). It is possible that 522 
while experience of IPV may hinder women’s ability to take HIV medication, it could alternately 523 
(or simultaneously) spur women towards persevering with HIV treatment.  524 
While motherhood was a protective element and a resilience strategy for some 525 
participants, this finding contains critical contradictions. Our findings reflect that women’s sense 526 
of self around the time of pregnancy can be grounded in the infant relationship (Bhandari et al., 527 
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2012), and that striving for motherhood may be an active coping strategy (Burnett et al., 2015; 528 
Foster et al., 2015). Motherhood can represent an important “turning point” when women start to 529 
consider leaving a violent relationship for the sake of the infant (Semaan et al., 2013: 74). 530 
However, there is a less positive aspect to the motherhood identity, as it necessarily expects that 531 
mothers will be the nurturing caretaker and sacrifice her own needs for that of her child (Hays, 532 
1998). When, in the context of IPV, women may not be fully able to protect their infants from 533 
psychological and physical harm, they may be held responsible for failure to protect the child, 534 
even as they themselves require protection (Lapierre, 2008). The shame associated with both IPV 535 
and HIV may be compounded with the shame of being a ‘bad mother’, which could only worsen 536 
mental and physical health outcomes. 537 
The pathway of partner non-disclosure seems to reveal both negative aspects of IPV as 538 
well as resilience strategies used by women. This tension between women being both constrained 539 
by the violence while also being agentic in their response has been highlighted in previous IPV 540 
literature (Campbell & Mannell, 2016; Turan et al., 2016). In our sample, partner non-disclosure 541 
made it challenging for some women to take treatment openly and consistently (Awiti Ujiji et al., 542 
2011). Yet, for others, non-disclosure was an important safety strategy. Women in this sample 543 
made strategic choices to stay safe from violent reprisals by placing medication in other 544 
containers, taking it at times when partners would be away, and by moving out from home 545 
altogether. Importantly, non-disclosure was also a method for regaining control over chaotic lives. 546 
It is important to note that this ‘agentic’ finding around non-disclosure strategies may have 547 
emerged partly because of our narrative approach to data collection. Constructing meaning 548 
through narratives is a particularly useful approach to violence research, as it restores agency and 549 
power among a group that is often considered the “helpless victim” (Boonzaier & van Schalkwyk, 550 
2011: 278). Notwithstanding the methodological considerations of this conclusion, the strong 551 
evidence from nine women in our cohort suggests that women do use important strategies to 552 
avoid partner disclosure while staying faithful to HIV medication adherence. 553 
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Pathways of partner control and mental health offered ‘negative’ influence on PMTCT 554 
behaviors. For several women, relationship control led to an inability to attend the clinic or take 555 
medication when desired (Lichtenstein, 2006). More often, however, partner control manifested 556 
as a sense of isolation and inability to define one’s own choices about health, movement outside 557 
the home, or taking care of the infant. The isolation caused by severe partner control meant that 558 
women had little access to social resources to help them (Liang et al., 2005). Isolation also 559 
contributed towards the mental health pathway, with women reporting increased anxiety and 560 
distress due to being alone.  561 
Our findings certainly support extant literature by suggesting that IPV leads to emotional 562 
trauma, anxiety, suicidal ideation, and depression among women, including in antenatal care 563 
(Ellsberg et al., 2008; Mahenge et al., 2013) and that poor mental health has onward impact on 564 
HIV medication adherence (Sumari-de Boer et al., 2012). We add to this evidence base by 565 
highlighting the complex underpinnings behind the IPV-mental health connection. On the more 566 
manageable side of the spectrum, women in violent relationships have stress and emotional 567 
concerns that take priority over the daily regimen of medication. For other women, on the more 568 
extreme side, a sense of hopelessness and being overwhelmed due to the extreme distress of 569 
violence led to the potential for self-harming behavior. In the six cases of women who described 570 
suicidal ideation, several used the act of stopping treatment as part of thoughts of ending their 571 
own lives. Others have noted that women’s vulnerability to abuse may create a self-image of 572 
being damaged, inhibiting self-care and access to regular health services (Leenerts, 1999; 573 
Rothenberg & Paskey, 1995). Our findings go beyond this literature by noting that HIV 574 
medication – due to its very necessity for good health – can be used in a self-harming manner 575 
through intentional treatment interruptions. 576 
 577 
Limitations 578 
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The findings of this study should be viewed in light of several limitations. All participants were 579 
visiting antenatal care, limiting our ability to understand these dynamics among women who 580 
avoid healthcare in pregnancy. Similarly, participants in this sample all reported IPV 581 
victimization (a majority with recent violent episodes), limiting a comparison to women living 582 
without IPV. Purposive selection of participants preclude our ability to generalize these data to 583 
the entire parent trial cohort, a limitation of most qualitative research. The urban Johannesburg 584 
setting has distinctions from other sub-Saharan African health settings, which makes it 585 
challenging to compare findings. Our narrative, social constructionist approach to interviews 586 
intentionally focused on techniques like validation, highlighting resistance, and locating identity 587 
within participant stories. Therefore, our interpretations are likely to differ from that of a ‘neutral 588 
observer’, as utilized within a more positivist research paradigm. Nevertheless, this study 589 
provides initial impressions of violence among HIV-positive pregnant/postpartum women in a 590 
sample that is larger than the extant literature. 591 
 592 
Implications for intervention, research & policy 593 
Several intervention strategies emerge from these data. With appropriate training, supervision, 594 
and tools, health workers in antenatal settings could be the first point of contact for pregnant, 595 
abused women. The ‘window of opportunity’ in antenatal care, when women are repeatedly 596 
visiting the clinic, can ensure that violence and HIV considerations are jointly addressed– 597 
particularly through onwards referral to services that specialise in addressing violence. The 598 
current method of group-based PMTCT messaging should be refined towards an individually-599 
tailored approach that truly addresses the concerns, confusions, and daily lives of pregnant and 600 
postpartum women. Open, honest discussions at this phase in a woman’s life may have benefits 601 
for staying safe while adhering to crucial PMTCT interventions. The notion of ‘striving for 602 
motherhood’ can also be harnessed during this time, to help women prioritize their own health 603 
and safety as another form of commitment to the infant. It is clear that the intertwined issues of 604 
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mental health and disclosure need to be incorporated into PMTCT services, and this can be 605 
achieved by training antenatal staff to implement brief mental health interventions or through 606 
referrals. Social support in the form of skillfully-facilitated peer support groups could assist 607 
women with the isolation pathway that is so pervasive in abusive partnerships.  608 
These qualitative findings suggest several avenues for further research. Given the 609 
potential positive and negative ways that violence may impact HIV adherence, future quantitative 610 
research should extend beyond simplistic analytic techniques. To date, the literature has been 611 
limited to bivariate association between violence and HIV adherence. Simple regression 612 
techniques may fail to account for important meditational pathways between IPV and adherence. 613 
In one recent study, for example, the direct association between IPV and HIV adherence was non-614 
significant, yet when mediated by mental health there was a strong negative path association 615 
(Malow et al., 2013). Specific pathways identified in this research should be explored and 616 
confirmed in a larger, quantitative sample using techniques that recognize the interrelated nature 617 
of pathways, such as structural equation modeling. 618 
PMTCT policy could also benefit from these qualitative findings. Current South African 619 
PMTCT guidelines discuss the “benefits” of partner HIV disclosure and prompt health workers to 620 
“encourage” disclosure and “support…partner notification” (South African Department of Health, 621 
2014: 37). However, no mention is made of the safety dilemmas that mothers may face in 622 
disclosing to a violent partner. We learned that partner non-disclosure is a strategic way to stay 623 
safe in a violent relationship, and that some women can manage to safely continue treatment 624 
without their partners finding out. Given that 25-35% of South African women experience IPV in 625 
pregnancy (Dunkle et al., 2004; Groves et al., 2012), the omission of strategic non-disclosure in 626 
current guidelines is likely to burden health workers, who are currently unskilled at discussing 627 
partner dynamics. 628 
 629 
Conclusion 630 
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IPV and HIV are strongly linked in the lives of childbearing women in many settings globally, 631 
and violence leads to adherence challenges that place maternal and infant health at risk. These 632 
intersecting issues deserve increased attention if we are to ensure elimination of vertical HIV 633 
transmission and protect the health of mothers globally. Current policy and intervention is sorely 634 
lacking, with little evidence that health workers and policy makers are alert to the considerations 635 
of violence within PMTCT programming. Pregnant and postpartum women will greatly benefit 636 
from antenatal care that recognizes the realities of living in violent relationships and emboldens 637 
women to prioritize their own health, as well as the health of their infants, during this critical 638 
phase. 639 
 640 
(Department of Health, 2014). (Boonzaier & van Schalkwyk, 2011) (Semaan et al., 2013)  641 
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